Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 14
2003 15
2004 10
2005 4
2006 11
2007 16
2008 19
2009 17
2010 15
2011 17
2012 22
2013 25
2014 18
2015 19
2016 25
2017 22
2018 22
2019 16
2020 25
2021 20
2022 16
2023 6
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

331 results

Results by year

Filters applied: . Clear all
Page 1
Emergent treatments for β-thalassemia and orphan drug legislations.
Costa E, Cappellini MD, Rivella S, Chilin A, Alessi E, Riccaboni M, Leufkens HGM, Luzzatto L. Costa E, et al. Among authors: leufkens hgm. Drug Discov Today. 2022 Nov;27(11):103342. doi: 10.1016/j.drudis.2022.103342. Epub 2022 Sep 1. Drug Discov Today. 2022. PMID: 36058507 Free article. Review.
Medicine shortages: impact behind numbers.
Postma DJ, Notenboom K, De Smet PAGM, Leufkens HGM, Mantel-Teeuwisse AK. Postma DJ, et al. Among authors: leufkens hgm. J Pharm Policy Pract. 2023 Mar 14;16(1):44. doi: 10.1186/s40545-023-00548-x. J Pharm Policy Pract. 2023. PMID: 36918981 Free PMC article.
Pre-Exposure Prophylaxis for HIV Prevention: Safety Concerns.
Tetteh RA, Yankey BA, Nartey ET, Lartey M, Leufkens HG, Dodoo AN. Tetteh RA, et al. Among authors: leufkens hg. Drug Saf. 2017 Apr;40(4):273-283. doi: 10.1007/s40264-017-0505-6. Drug Saf. 2017. PMID: 28130774 Free PMC article. Review.
Four scenarios for the future of medicines and social policy in 2030.
Leufkens HG, Kusynová Z, Aitken M, Hoekman J, Stolk P, Klein K, Mantel-Teeuwisse AK. Leufkens HG, et al. Drug Discov Today. 2022 Aug;27(8):2252-2260. doi: 10.1016/j.drudis.2022.03.018. Epub 2022 Mar 29. Drug Discov Today. 2022. PMID: 35364271 Free article. Review.
Factors related to drug approvals: predictors of outcome?
Liberti L, Breckenridge A, Hoekman J, McAuslane N, Stolk P, Leufkens H. Liberti L, et al. Among authors: leufkens h. Drug Discov Today. 2017 Jun;22(6):937-946. doi: 10.1016/j.drudis.2017.03.003. Epub 2017 Mar 10. Drug Discov Today. 2017. PMID: 28288783 Review.
Traceability of biologicals: present challenges in pharmacovigilance.
Vermeer NS, Spierings I, Mantel-Teeuwisse AK, Straus SM, Giezen TJ, Leufkens HG, Egberts TC, De Bruin ML. Vermeer NS, et al. Among authors: leufkens hg. Expert Opin Drug Saf. 2015 Jan;14(1):63-72. doi: 10.1517/14740338.2015.972362. Epub 2014 Nov 5. Expert Opin Drug Saf. 2015. PMID: 25369769 Review.
Switching TNFα inhibitors: Patterns and determinants.
Meijboom RW, Gardarsdottir H, Becker ML, de Groot MCH, Movig KLL, Kuijvenhoven J, Egberts TCG, Leufkens HGM, Giezen TJ. Meijboom RW, et al. Among authors: leufkens hgm. Pharmacol Res Perspect. 2021 Aug;9(4):e00843. doi: 10.1002/prp2.843. Pharmacol Res Perspect. 2021. PMID: 34302442 Free PMC article.
331 results